Always eat a healthy, balanced diet. Consult a registered healthcare professional if you have a medical condition, take chronic medication, suffer from food allergies, follow a specific diet, or are considering weight-loss medication. This article is for informational purposes only and does not constitute medical advice.
Metabolic health is the body’s ability to regulate blood glucose, insulin response, blood pressure, blood fats, inflammation and fat storage in a way that supports normal energy use and lowers the risk of conditions such as type 2 diabetes, cardiovascular disease, fatty liver disease and obesity-related complications.
GLP-1 medicines represent a major breakthrough in the treatment of obesity and type 2 diabetes and can be highly effective when prescribed appropriately and supported by the right nutrition, lifestyle and medical care.
Most people think metabolic health is about weight.
That is only partly true.
Weight matters, but it is not the full picture. A person can lose weight and still have poor metabolic health if they are losing muscle, eating too little protein, sleeping badly, living under constant stress, or relying mainly on ultra-processed convenience foods.
A better question is: Is my body handling the energy I consume well?
That question matters because metabolic health often declines quietly. Blood sugar rises. Waist size increases. Blood pressure creeps up. Triglycerides rise. Energy crashes become normal. Hunger and cravings feel harder to control. Sleep gets worse.
The body may be sending signals, but many people only listen once a doctor gives the problem a name. Taking control of metabolic health early can help you make better decisions about nutrition, lifestyle and, where medically appropriate, GLP-1 treatment. This should always be done with proper medical advice, nutritional support and exercise guidance.
Are our food environment and sedentary lifestyles driving poor metabolic health?
The World Health Organization reports that in 2022, 2.5 billion adults were overweight, and 890 million adults were living with obesity. Adult obesity has more than doubled since 1990.
This is not simply a personal willpower problem. It is a global metabolic health problem.
The signs most people delay checking
The following signs do not prove that you have metabolic syndrome, diabetes or another condition. They are not a diagnosis. But they are good reasons to speak to a healthcare professional and get measured properly.
Body signals to notice
- Increasing waist size Strong cravings or constant “food noise” Tiredness after meals Afternoon energy crashes Poor sleep or waking unrefreshed Snoring or possible sleep apnoea symptoms Repeated weight regain after dieting Feeling unable to control hunger despite effort
Medical risk flags
- Family history of type 2 diabetes or heart disease
- Previous gestational diabetes
- Known fatty liver or raised liver enzymes
- Polycystic ovary syndrome
- Existing diabetes, insulin resistance or prediabetes
- Use of medication that may affect weight, glucose or appetite
These are not character flaws. They are biological, behavioural and environmental signals that should be understood, measured and discussed with a healthcare professional.
The practical rule
Do not start with a diet. Start with a baseline.
Before changing everything, measure where you are. Discuss the tests and measurements above with your doctor, and ask whether any additional checks are needed based on your health history.
Start keeping a record. At home, start tracking:
- Weight and waist size
- Sleep quality and energy
- Meals, hunger, energy after meals and cravings
- Protein, fibre, carbohydrates and calories consumed per day, if you do not already track these
- Water intake
- Activity levels, steps, movement and training
A baseline turns vague anxiety into a clear map. It helps you stop guessing. If you are considering a GLP-1 journey, it also gives you and your healthcare team a clear starting point.
Why this matters before a GLP-1 journey
GLP-1 medicines, such as semaglutide and tirzepatide, can support significant weight loss and improve important metabolic risk markers when prescribed appropriately. They act on appetite, satiety, blood glucose and digestive signalling. Because they can also change eating patterns and may cause side effects such as nausea, vomiting, diarrhoea, constipation, reflux, bloating, low appetite and reduced food or fluid intake, medical supervision and dietitian support are important.
Nutrition should not be treated as an afterthought.
The Full-on NutriScience view
Long-term metabolic health should not rely only on chronic medication. Medication may be an important part of care, but lasting metabolic health also depends on nutrition, movement, sleep, muscle preservation and long-term support.
GLP-1 medication can assist in starting the process, but it does not remove the need for nutrition. It makes nutrition more important.
When appetite drops, you will probably eat less and may tolerate different foods. If you eat less, every bite must work harder. Protein, fibre, micronutrients, fluids and electrolytes become central to supporting energy, digestion, muscle and long-term health.
The nutritional risk on a GLP-1 journey is that changed eating patterns may lead to inadequate protein, fibre, fluids or micronutrients. Some people may also struggle with side effects that make eating enough of the right foods more difficult.
That is why you need to understand and prepare your new eating pattern before you feel lost or unsure what to eat.
The goal is not simply to eat less.
Build a metabolic-health operating system
- Know your GLP-1 starting measurements.
- Determine the appropriate medicine, dose and treatment plan with your doctor.
- Manage potential side effects early, including nausea, vomiting, reduced food and fluid intake, diarrhoea, constipation, gas, bloating, reflux, weakness or poor appetite. These symptoms can vary from mild to severe and should be discussed with your healthcare provider, especially if they are persistent or worsening.
- Protect muscle.
- Prioritise protein.
- Build fibre gradually.
- Avoid ultra-processed convenience foods.
- Improve sleep.
- Move more daily.
- Bring strength training into your routine.
- Plan for a long-term metabolic maintenance lifestyle from the start.
The mistake is thinking the GLP-1 journey starts when the injection starts. It starts when you realise you can build a healthier metabolic lifestyle.
When to contact your doctor
If you are considering medication for your weight loss journey, speak to your doctor first.
Also speak to your doctor, dietitian or diabetes educator if you have diabetes, kidney disease, heart disease, gallbladder disease, a history of pancreatitis, pregnancy, planned pregnancy, severe reflux, a history of an eating disorder, unexplained weight loss, persistent vomiting, severe constipation or symptoms of low blood sugar.
Do not self-prescribe or use compounded, falsified or unregistered products. In South Africa, SAHPRA has warned the public about unauthorised, falsified, compounded and substandard GLP-1 products being sold online and through social media channels.
Frequently asked questions
What is metabolic syndrome?
Metabolic syndrome is a cluster of risk factors that often includes increased waist circumference, high blood glucose, high blood pressure, high triglycerides and low HDL cholesterol. When several of these are present together, they increase the risk of type 2 diabetes, cardiovascular disease and stroke.
Should I lose weight before improving my diet?
Improving diet quality, protein intake, fibre intake, sleep and movement can begin immediately and is the starting point of the weight loss journey.
Why is waist size important?
Waist size is a practical marker of abdominal fat, which is closely linked with metabolic risk. It should be interpreted with other measurements, not in isolation.
Is metabolic health reversible?
Many markers can improve with weight loss, better nutrition, physical activity, sleep improvement, medication where appropriate and long-term support. The right plan depends on the individual and should be guided by a healthcare professional.
Sources
World Health Organization. Obesity and overweight. 8 December 2025.
American Heart Association. Symptoms and Diagnosis of Metabolic Syndrome.
American Diabetes Association. Standards of Care in Diabetes — 2026.
Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021.
The Obesity Society, American College of Lifestyle Medicine, American Society for Nutrition and Obesity Medicine Association. Nutritional Priorities to Support GLP-1 Therapy for Obesity. 2025.
SAHPRA. Position on GLP-1 and GIP/GLP-1 products that are compounded, substandard and falsified. 2024.
SAHPRA. Warning on GLP-1 products sold through social media platforms. 2025.